These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37549932)

  • 1. Tissue factor pathway inhibitor 2: Current understanding, challenges, and future perspectives.
    Kobayashi H; Matsubara S; Yoshimoto C; Shigetomi H; Imanaka S
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2575-2583. PubMed ID: 37549932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia.
    Kobayashi H; Matsubara S; Yoshimoto C; Shigetomi H; Imanaka S
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tissue factor pathway inhibitor 2 in the coagulation and fibrinolysis system.
    Kobayashi H; Matsubara S; Imanaka S
    J Obstet Gynaecol Res; 2023 Jul; 49(7):1677-1683. PubMed ID: 37186495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.
    Miyagi E; Arakawa N; Sakamaki K; Yokota NR; Yamanaka T; Yamada Y; Yamaguchi S; Nagao S; Hirashima Y; Kasamatsu Y; Kato H; Mogami T; Miyagi Y; Kobayashi H
    Int J Clin Oncol; 2021 Jul; 26(7):1336-1344. PubMed ID: 34009487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
    Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
    PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix.
    Ota Y; Koizume S; Nakamura Y; Yoshihara M; Takahashi T; Sato S; Myoba S; Ohtake N; Kato H; Yokose T; Miyagi E; Miyagi Y
    Oncol Rep; 2021 Mar; 45(3):1023-1032. PubMed ID: 33650653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma.
    Arakawa N; Miyagi E; Nomura A; Morita E; Ino Y; Ohtake N; Miyagi Y; Hirahara F; Hirano H
    J Proteome Res; 2013 Oct; 12(10):4340-50. PubMed ID: 23805888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.
    Yamanaka S; Miyake R; Yamada Y; Kawaguchi R; Ootake N; Myoba S; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(2):133-140. PubMed ID: 35613543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-616-3p modulates cell proliferation and migration through targeting tissue factor pathway inhibitor 2 in preeclampsia.
    Xu Y; Wu D; Jiang Z; Zhang Y; Wang S; Ma Z; Hui B; Wang J; Qian W; Ge Z; Sun L
    Cell Prolif; 2018 Oct; 51(5):e12490. PubMed ID: 30028057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of TFPI2 correlates with cervical cancer incidence in the Uygur and Han populations of Xinjiang, China.
    Dong Y; Tan Q; Tao L; Pan X; Pang L; Liang W; Liu W; Zhang W; Li F; Jia W
    Int J Clin Exp Pathol; 2015; 8(2):1844-54. PubMed ID: 25973077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward an understanding of tissue factor pathway inhibitor-2 as a novel serodiagnostic marker for clear cell carcinoma of the ovary.
    Kobayashi H; Imanaka S
    J Obstet Gynaecol Res; 2021 Sep; 47(9):2978-2989. PubMed ID: 34184357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.
    Hibi K; Goto T; Kitamura YH; Yokomizo K; Sakuraba K; Shirahata A; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2010 Apr; 30(4):1205-7. PubMed ID: 20530429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the efficacy of tissue factor pathway inhibitor‑2 as a promising prognostic marker for ovarian cancer.
    Maehana T; Kawaguchi R; Nishikawa K; Kawahara N; Yamada Y; Kimura F
    Oncol Lett; 2024 Jul; 28(1):302. PubMed ID: 38774455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.
    Glöckner SC; Dhir M; Yi JM; McGarvey KE; Van Neste L; Louwagie J; Chan TA; Kleeberger W; de Bruïne AP; Smits KM; Khalid-de Bakker CA; Jonkers DM; Stockbrügger RW; Meijer GA; Oort FA; Iacobuzio-Donahue C; Bierau K; Herman JG; Baylin SB; Van Engeland M; Schuebel KE; Ahuja N
    Cancer Res; 2009 Jun; 69(11):4691-9. PubMed ID: 19435926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
    Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2012 Mar; 32(3):787-90. PubMed ID: 22399594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of
    Hu H; Chen X; Wang C; Jiang Y; Li J; Ying X; Yang Y; Li B; Zhou C; Zhong J; Wu D; Ying J; Duan S
    Oncotarget; 2017 Oct; 8(48):84054-84065. PubMed ID: 29137404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of TFPI2 methylation in the serum of gastric cancer patients.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0015382 is associated with preeclampsia and regulates biological behaviors of trophoblast cells through miR-149-5p/TFPI2 axis.
    Hu Z; Dong C; Dong Q
    Placenta; 2021 May; 108():73-80. PubMed ID: 33819864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.